Boston Scientific

Boston Scientific Corporation
Company typePublic
ISINUS1011371077
IndustryMedical device
FoundedJune 29, 1979; 45 years ago (1979-06-29) in Watertown, Massachusetts
Founders
HeadquartersMarlborough, Massachusetts, U.S.
Key people
RevenueIncrease US$14.24 billion (2023)[1]
Increase US$2.343 billion (2023)[1]
Increase US$1.592 billion (2023)[1]
Total assetsIncrease US$35.14 billion (2023)[1]
Total equityIncrease US$19.28 billion (2023)[1]
Number of employees
c. 48,000[1] (2023)
Websitebostonscientific.com

42°21′37.3″N 71°33′32.6″W / 42.360361°N 71.559056°W / 42.360361; -71.559056 Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware,[2] is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries.[3] With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM subcutaneous implantable defibrillator (S-ICD).[4][5]